✦ LIBER ✦

Therapeutic and Toxicologic Evaluation of Anti-Lipogenic Agents in Cancer Cells Compared with Non-Neoplastic Cells

✍ Scribed by Perinkulam Ravi Deepa; Suryanarayanan Vandhana; Udayakumar Jayanthi; Subramanian Krishnakumar

Book ID: 114826724
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 746 KB
Volume: 110
Category: Article
ISSN: 1742-7835
DOI: 10.1111/j.1742-7843.2011.00844.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic evaluation of gemcitabine singl

Economic evaluation of gemcitabine single agent therapy compared with standard treatment in stage IIIB and IV non-small cell lung cancer

✍ Gunnel Ragnarson Tennvall; Jan-Olof Fernberg 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 978 KB

Re-examination of Maintenance Therapy in

Re-examination of Maintenance Therapy in Non-Small Cell Lung Cancer with the Advent of New Anti-cancer Agents

✍ Eamon M. Berge, Robert C. Doebele 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 343 KB

Therapeutic evaluation of cisplatin, vin

Therapeutic evaluation of cisplatin, vindesine, and mitomycin C therapy in advanced non-small-cell lung cancer

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Editorial: Comparative efficacy and cost

Editorial: Comparative efficacy and cost associated with new agents in the treatment of non-small cell lung cancer (NSCLC)

✍ Mueller, Elvira 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Evaluation and Prognostic Significance o

Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer

✍ Krebs, M. G.; Sloane, R.; Priest, L.; Lancashire, L.; Hou, J.-M.; Greystoke, A.; 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 266 KB

Benefits and limitations of antiangiogen

Benefits and limitations of antiangiogenic agents in patients with non-small cell lung cancer

✍ Bertino, Erin M.; Otterson, Gregory A. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 231 KB